Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Confirmatory Validation of Oral Macimorelin as a Growth Hormone (GH) Stimulation Test (ST) for the Diagnosis of Adult Growth Hormone Deficiency (AGHD) in Comparison With the Insulin Tolerance Test (ITT)

NCT02558829 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT02558829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02558829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Confirmatory Validation of Oral Macimorelin as a Growth Hormone (GH) Stimulation Test (ST) for the Diagnosis of Adult Growth Hormone Deficiency (AGHD) in Comparison With the Insulin Tolerance Test (ITT)
Lead sponsor
AEterna Zentaris
Phase
Phase 3
Overall status
Completed
Start date
December 3, 2015
Completion date
November 29, 2016
Enrollment
157 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency with pituitary anomalies